VP: 98% of Needed Drugs Produced inside Iran

“At present, 98% of the needed drugs for people is produced inside the country and our companies have acted well in area of food and drug and necessary and basic commodities for people,” Sattari told FNA on Monday.

Elsewhere, he underlined Iran’s production and exports of nanotechnology products to foreign countries, and said, “We have planned to have over 10,000 new startups and over 300 accelerators by 2022.”

In similar remarks in September, Sattari announced that the country’s experts had been able to obviate nearly all people’s needs to medicine irrespective of the United States’ harsh sanctions.

“Our researchers have bypassed the sanctions in all scientific fields,” Sattari told FNA.

“At present, 98% of the drugs needed by our country’s people is produced inside the country and by our researchers,” he added.

Sattari underscored that the US sanctions have certainly created some problems for Iran, but such problems are not too big and too major to be resolved by Iranian researchers.

Iran in September unveiled 6 new drugs produced by the country’s experts with applications for MS, diabetes, cancer and cardiovascular patients.

The 6 drugs were unveiled in the presence of Head of Food and Drug Administration of Iran Mohammad Reza Shanehsaz.

The medicines named Giomide, Norabex, Neurapa, Lotiva, Glorenta and Elacoite are for the treatment MS, diabetes, cancer and cardiovascular diseases.

Also, in August, Iran unveiled 6 new indigenized knowledge-based products with medical uses.

The products which were unveiled at Shiraz University of Medical Sciences have all been manufactured by Iranian experts.

They include absorbable and non-absorbable surgical yarn, Dia Diet chocolate usable by diabetic patients, haptic technology, also known as kinaesthetic communication or 3D touch, which refers to any technology that can create an experience of touch by applying forces, vibrations, or motions to the user, laparoscopy set for operations performed in the abdomen or pelvis using small incisions with the aid of a camera, video laryngoscopes (VLs), which are rigid devices that allow indirect laryngoscopy or visualization of the vocal cords and related airway structures without a direct line of sight, and the technology to extract and purify compounds of medicinal plants.

Also, Sattari in July unveiled 8 new drugs during his a visit to the knowledge-based companies in Alborz province near Tehran.

The newly-developed drugs include Micro-Peltamparazole, Tamsulosin hydrochloride, Naltrexone base, Citalyptin phosphate, Peo Gliatzone and other medicine.

The drugs have applications in treatment of digestive diseases and intestinal insufficiency, and will also be exported to the regional states.